Ireland· IE-PA-PA2028/002/002
CitraFleet oral solution
A natrium-picosulfat, kombinationen product containing sodium picosulfate + magnesium oxide, light + citric acid, registered in Ireland by Casen-Recordati S.L.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Natrium-picosulfat, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC A06AB58 (natrium-picosulfat, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Natrium-picosulfat, kombinationen · ATC A06AB58
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Sodium picosulfate + Magnesium oxide, light + Citric acid
- Manufacturer
- Casen-Recordati S.L.
- Country
- Ireland (IE)
- ATC code
- A06AB58
- ATC class
- Natrium-picosulfat, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2028/002/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natrium-picosulfat, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCITRAFLEETCasen Recordati, S.L., Utebo, Zaragoza
- FinlandCitraFleetCasen Recordati, S.L.
- CanadaPICO-SALAXFERRING INC
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Ácido Cítrico + Óxido De Magnésio + Picossulfato De Sódio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/409a561a-69af-4154-838c-e4f56bd1bfdb GET /v1/drugs/409a561a-69af-4154-838c-e4f56bd1bfdb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AB58"
],
"strength": null,
"pa_number": "PA2028/002/002",
"substances": [
"Sodium picosulfate",
"Magnesium oxide, light",
"Citric acid"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "03/03/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about natrium-picosulfat, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.